ANTX AN2 Therapeutics, Inc.
USHealthcareAs of 2026-08-24
Why ANTX matters now
AN2 Therapeutics, Inc. (ANTX) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.63 with -3.10% on the session and $202.8M in market capitalization; recent performance reads 1-month +9.89% and YTD +338.60%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-10.0M, and EPS of $-0.29. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -22.8%.
The latest indexable market news headline is "AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $9.00; recent insider activity includes Williams Sarah Joanne filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.08
P/S
0.00
EV/EBITDA
-2.33
DCF Value
$0.59
FCF Yield
-22.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-52.3%
ROA
-39.5%
ROIC
-45.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-10.0M | $-0.29 |
| Q4 2025 | $0.00 | $-8.7M | $-0.29 |
| FY 2025 | $0.00 | $-35.2M | $-1.16 |
| Q3 2025 | $0.00 | $-9.4M | $-0.31 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$9.00
Target (Median)
$9.00
Target Range
$9.00 - $9.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
-0.98
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.